Literature DB >> 28219868

[Effects of Sinopodophyllum hexundrum on apoptosis in K562 cells].

Fang-Zhu Zhou1, Xin Wang, An-Ya Dai, Zheng-Lan Huang, Hui Li, Ning-Shu Huang, Wen-Li Feng.   

Abstract

OBJECTIVE: To investigate the effects of Sinopodophyllum hexundrum on apoptosis in K562 cells.
METHODS: K562 cells were treated with Sinopodophyllum hexundrum at different concentrations and for different lengths of time to determine the optimal conditions of SinoPodophyllum hexandrum treatment for K562 cells using CCK8 assay. The cell apoptotic rate was detected by flow cytometry, and the cell morphology and nuclear morphology of K562 cells were observed with Wright staining and DPAI staining, respectively. The protein expressions of BCR/ABL, p-BCR/ABL, STAT5, p-STAT5 and the apoptosis-related proteins PARP, caspase-3 and cleaved-caspase-3 were determined with Western blotting.
RESULTS: The cell proliferation was inhibited in a concentration-and time-dependent manner by 1, 2, and 3 µg/mL Sinopodophyllum hexundrum. The treatment was optimal with a Sinopodophyllum hexundrum concentration of 2 µg/mL a treatment time of 48 h, and the cell apoptotic rate increased in a time-dependent manner and significantly increased at 48 h (P<0.001). The expression of apoptosis-related proteins PARP, caspase-3 and cleaved-caspase-3 were also activated in a time-dependent manner. The cells showed typical apoptotic changes after treatment with 2 µg/mL Sinopodophyllum hexundrum for 48 h with significantly reduced expressions of BCR/ABL, p-BCR/ABL, STAT5, AND p-STAT5.
CONCLUSION: Sinopodophyllum hexundrum promotes K562 cell apoptosis possibly by inhibiting BCR/ABL-STAT5 survival signal pathways and activating the mitochondrion-associated apoptotic pathways.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28219868      PMCID: PMC6779673     

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  12 in total

Review 1.  Multifaceted mechanisms for cell survival and drug targeting in chronic myelogenous leukemia.

Authors:  J Kuroda; Y Shimura; M Yamamoto-Sugitani; N Sasaki; M Taniwaki
Journal:  Curr Cancer Drug Targets       Date:  2013-01       Impact factor: 3.428

2.  [Resources of survey in rare and endangered medicinal plant Sinopodophyllum emodi].

Authors:  Jifeng Zhao; Xiang Liu; Changhua Wang; Zhiwei Zhang; Songyun Qin; Guoyue Zhong
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2011-05

Review 3.  Front-line and salvage therapies with tyrosine kinase inhibitors and other treatments in chronic myeloid leukemia.

Authors:  Jorge Cortes; Andreas Hochhaus; Timothy Hughes; Hagop Kantarjian
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

Review 4.  Evolution of therapies for chronic myelogenous leukemia.

Authors:  Fabio P S Santos; Hagop Kantarjian; Alfonso Quintás-Cardama; Jorge Cortes
Journal:  Cancer J       Date:  2011 Nov-Dec       Impact factor: 3.360

5.  The inhibition of ERK/MAPK not the activation of JNK/SAPK is primarily required to induce apoptosis in chronic myelogenous leukemic K562 cells.

Authors:  C D Kang; S D Yoo; B W Hwang; K W Kim; D W Kim; C M Kim; S H Kim; B S Chung
Journal:  Leuk Res       Date:  2000-06       Impact factor: 3.156

6.  Investigation of podophyllotoxin esters as potential anticancer agents: synthesis, biological studies and tubulin inhibition properties.

Authors:  Mohd Adil Shareef; Divya Duscharla; G Ramasatyaveni; Neha R Dhoke; Amitava Das; Ramesh Ummanni; Ajay Kumar Srivastava
Journal:  Eur J Med Chem       Date:  2014-10-18       Impact factor: 6.514

Review 7.  Molecular biology of bcr-abl1-positive chronic myeloid leukemia.

Authors:  Alfonso Quintás-Cardama; Jorge Cortes
Journal:  Blood       Date:  2008-09-30       Impact factor: 22.113

Review 8.  Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia.

Authors:  Ellen Weisberg; Paul W Manley; Sandra W Cowan-Jacob; Andreas Hochhaus; James D Griffin
Journal:  Nat Rev Cancer       Date:  2007-05       Impact factor: 60.716

Review 9.  Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy.

Authors:  J A McCubrey; L S Steelman; S L Abrams; F E Bertrand; D E Ludwig; J Bäsecke; M Libra; F Stivala; M Milella; A Tafuri; P Lunghi; A Bonati; A M Martelli
Journal:  Leukemia       Date:  2008-03-13       Impact factor: 11.528

10.  Antitumor activity of deoxypodophyllotoxin isolated from Anthriscus sylvestris: Induction of G2/M cell cycle arrest and caspase-dependent apoptosis.

Authors:  Yeonjoong Yong; Soon Young Shin; Young Han Lee; Yoongho Lim
Journal:  Bioorg Med Chem Lett       Date:  2009-05-28       Impact factor: 2.823

View more
  1 in total

1.  Mining Therapeutic Efficacy from Treasure Chest of Biodiversity and Chemodiversity: Pharmacophylogeny of Ranunculales Medicinal Plants.

Authors:  Da-Cheng Hao; Li-Jia Xu; Yu-Wei Zheng; Huai-Yu Lyu; Pei-Gen Xiao
Journal:  Chin J Integr Med       Date:  2022-07-09       Impact factor: 2.626

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.